Phenacemide
From Wikipedia, the free encyclopedia
Image:Phenacemide.png | |
Phenacemide
|
|
Systematic (IUPAC) name | |
N-carbamoyl-2-phenyl-acetamide | |
Identifiers | |
CAS number | 63-98-9 |
ATC code | N03AX07 |
PubChem | 4753 |
DrugBank | APRD00089 |
Chemical data | |
Formula | C9H10N2O2 |
Mol. weight | 178.188 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | 22-25 hours. |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Phenacemide is an anticonvulsant of the urea class.
[edit] External links
- DDB 34078
- MedlinePlus DrugInfo uspdi-202454
- Coker S (1986). "The use of phenacemide for intractable partial complex epilepsy in children". Pediatr Neurol 2 (4): 230-2. PMID 3508693.
- Coker S, Holmes E, Egel R (1987). "Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations". Neurology 37 (12): 1861-6. PMID 3683877.